Clinical Trial Update: Gut Microbiota Dysbiosis and Translocation During IBD and Parkinson [NA]

View source ↗

Summary

Completed clinical trial evaluating gut microbiota dysbiosis and translocation in inflammatory bowel disease and Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease
• Parkinson Disease

Snippet

Sponsor: Hôpital Européen Marseille | Conditions: Inflammatory Bowel Diseases, Parkinson Disease | NA | Status: COMPLETED